Dentists in Hagatna, GU Accepting Medicare
7 Dentists found. Showing 1 - 7
 Mr. Jeffrey C. Johnson, D.D.S. Dentist - General Practice Medicare: Not Enrolled in Medicare Practice Location: 250 Route 4 Ste 101, Hagatna, GU 96910 Phone: 671-646-7982 Fax: 671-646-7989 |
Mr. Rayner D. Terlaje, D.D.S.,M.S. Dentist - Pediatric Dentistry Medicare: Not Enrolled in Medicare Practice Location: 250 Route 4 Ste 101, Hagatna, GU 96910 Phone: 671-646-7982 Fax: 671-646-7989 |
Kunsun Lee Dentist Medicare: Medicare Enrolled Practice Location: 222 E Chalan Santo Papa Ste 304, Hagatna, GU 96910 Phone: 671-472-6824 |
 Dr. Backhabwha Kim, DDS Dentist Medicare: Medicare Enrolled Practice Location: 222 E Chalan Santo Papa Ste 304, Hagatna, GU 96910 Phone: 671-472-6824 |
Jeffrey David Ives Dentist Medicare: Not Enrolled in Medicare Practice Location: 222 E Chalan Santo Papa, #304 Reflection Center, Hagatna, GU 96910 Phone: 671-472-6824 |
Gerson Sanchez Valles, D.D.S. Dentist Medicare: Not Enrolled in Medicare Practice Location: 414 W Soledad Ave Ste 300, Hagatna, GU 96910 Phone: 671-472-2489 Fax: 671-477-9275 |
Robert Roy Gatewood, D.D.S., M.S., PERIOD Dentist - Periodontics Medicare: Not Enrolled in Medicare Practice Location: 222 East Chalan Santo Papa, Suite 303, Hagatna, GU 96910 Phone: 671-477-2379 Fax: 671-477-2387 |
News Archive
PD-1 protein could serve as biomarker for predicting survival of lung cancer patients
The biomarker PD-1, a protein, could potentially be used to predict survival or disease-free survival of lung cancer patients who have had the tumour surgically removed.
MAP Pharmaceuticals reports results from LEVADEX PK and safety clinical trial in smokers, non-smokers
MAP Pharmaceuticals, Inc. today announced results from a clinical trial comparing the pharmacokinetics (PK) and safety of LEVADEX™ orally inhaled migraine therapy with intravenous dihydroergotamine mesylate (DHE) in smokers and non-smokers. The trial was designed to measure whether systemic absorption and exposure in smokers is greater than in non-smokers. In the trial, the systemic absorption of LEVADEX was not higher and systemic exposure to DHE was not greater in smokers than in non-smokers.
Targeted nanoparticles deliver therapeutic DNA to cancer cells
Given that cancer is a disease caused by gene mutations, cancer researchers have been striving to develop gene therapies aimed at correcting these mutations. However, these efforts have been hobbled by the difficulty in safely and efficiently delivering anticancer genes to tumors. Nanoparticles, however, may solve these delivery issues, and two recently published studies, using two different types of nanoparticles, lend credence to that hypothesis.
Brain areas linked to social behaviors underdeveloped in youths with high functioning ASD
A team of UCLA scientists has found that brain areas linked to social behaviors are both underdeveloped and insufficiently networked in youths with high functioning autism spectrum disorder (ASD) compared to study participants without ASD.
› Verified 4 days ago